Clearmind Medicine Inc.
CMND Nasdaq
SEC CIK 1892500
Follow Clearmind Medicine
Weekly email: filings, results
Net income
−$3.9M
−259.7% vs same quarter last year
EPS, diluted
−$3.32
Operating cash flow
−$2.1M
−64.8% vs same quarter last year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY25 | −$3.9M |
| FY24 | −$5.3M |
| FY23 | −$8.6M |
| FY22 | −$6.9M |
| FY21 | −$2.7M |
| FY20 | - |